 Shares of MannKind Corp. MNKD, -17.68 tumbled 18.3 in trading on Monday after the company said the Food and Drug Administration would not approve a pulmonary arterial hypertension treatment it is developing with United Therapeutics Corp. UTHR, -2.50 . Uniteds stock was down 2.6. 